Home

KraneShares MSCI All China Health Care Index ETF (KURE)

16.76
+0.00 (0.00%)
NYSE · Last Trade: Jun 24th, 7:01 AM EDT
QuoteNewsPress ReleasesChartHistorical

Detailed Quote

Previous Close16.76
Open-
Day's RangeN/A - N/A
52 Week Range12.91 - 20.51
Volume18
Market Cap896.66K
Dividend & Yield0.1840 (1.10%)
1 Month Average Volume39,939

Chart

News & Press Releases

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'benzinga.com
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via Benzinga · June 20, 2025
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortionbenzinga.com
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
Via Benzinga · May 19, 2025
3 ETFs Thriving in April’s Market Chaos—Are You Missing Out?
These ETFs beat the S&P 500 in April 2025’s turbulent market. Learn how TOLZ, VIXY, and KURE can help stabilize your investment strategy.
Via MarketBeat · April 15, 2025
China Stocks Look Set For A Rebound, Morgan Stanley Quant Strategists Saybenzinga.com
Investors in mainland China are rapidly unwinding their stock-index hedges, in an indication that a possible end to Chengdu’s lockdown and policies to stabilize the yuan will lead to a near-term market rally, reported 
Via Benzinga · September 13, 2022
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companiesbenzinga.com
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
Via Benzinga · April 11, 2025
China's Market Rebound: Is The NPC Meeting A Turning Point For Investors?benzinga.com
China's NPC meeting has sparked optimism in the market, with Chinese stocks and bonds rallying. Investors are hopeful for growth targets but remain skeptical.
Via Benzinga · March 7, 2025